Evidence map›Paper›PMID 27858218›Full record

ArticlePharmaceutical research2017

Bleomycin-Coated Microneedles for Treatment of Warts.

Han Sol Lee, Ha Ryeong Ryu, Joo Young Roh, Jung-Hwan Park

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Efficacy of a bleomycin microneedle patch for the treatment of warts.Drug delivery and translational research · 2018
    Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Microneedle-mediated drug delivery for cutaneous diseases.Frontiers in bioengineering and biotechnology · 2022
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Current trends in polymer microneedle for transdermal drug delivery.International journal of pharmaceutics · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Han Sol LeeDepartment of BioNano Technology and Gacheon BioNano Research Institute, Gachon University, Seongnam, Korea.
Ha Ryeong RyuDepartment of Dermatology, Gachon University Gil Medical Center, Incheon, Korea.
Joo Young RohDepartment of Dermatology, Gachon University Gil Medical Center, Incheon, Korea. jyroh1@gilhospital.com.
Jung-Hwan ParkDepartment of BioNano Technology and Gacheon BioNano Research Institute, Gachon University, Seongnam, Korea. pa90201@gachon.ac.kr.
Gachon University · KRGachon University Gil Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBleomycin-coated microneedles were devised for delivery of bleomycin into the sub-epidermal skin layer for the treatment of warts in order to provide patient convenience and reduce patient pain and fear.

methodPoly-lactic-acid (L-PLA) microneedles were fabricated by a molding process and then the tips were partially coated using a dip-coating method based on a microstructure well. The mechanical strength of the pre-coated polymer microneedles was observed by inserting them in porcine foot and back skin. The holes were stained with trypan blue and the mechanical failure of the microneedles was investigated using a scanning electron microscope (SEM). The initial distribution of a model drug using microneedles was compared with distribution by intralesional injection. The amount of drug leaked below the skin using microneedles was measured and compared with that leaked by intralesional injection. The pharmacokinetic properties of bleomycin-coated microneedles were studied. The bleomycin remaining on the coated microneedles after the in vivo pharmacokinetic study was measured.

resultsBleomycin was successfully coated on the tips of L-PLA microneedles. More than 80% of the bleomycin dissolved into the skin in vitro within 15 min. L-PLA microneedles possessed sufficient mechanical strength to penetrate skin with a thick stratum corneum. Compared to intralesional injection, tip-coated microneedles were more effective in distributing a drug into the sub-epidermal skin layer. A pharmacokinetic study of bleomycin-coated microneedles showed 50 min of T

conclusionsBleomycin-coated microneedles appeared to be a convenient and painless alternative to conventional intralesional injection of bleomycin. The microneedles delivered bleomycin into the targeted dermal layer regardless of body site. Bleomycin-coated microneedles therefore provide a suitable method for the treatment of warts.

Indexed as

Administration, CutaneousAnimalsBleomycinDrug Delivery SystemsEquipment DesignExcipientsInjections, IntralesionalMicroinjectionsNeedlesPolyestersPolymersSkinSwineWartsBleomycinExcipientsPolyesterspoly(lactide)Polymersbleomycincoated microneedlelocal deliverymechanical strengthwarts

Identifiers

PMID27858218
OpenAlexW2555127470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.